A Novel In Vivo Method Using <i>Caenorhabditis elegans</i> to Evaluate α-Glucosidase Inhibition by Natural Products for Type 2 Diabetes Treatment
Background: Non-insulin-dependent diabetes mellitus, or type 2 diabetes, is one of the diseases of greatest concern worldwide, and research into natural compounds that are capable of regulating glycemia and insulin resistance is therefore gaining importance. In the preclinical stages, <i>Caenorhabdi...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI AG
2024-12-01
|
| Seri Bilgileri: | Pharmaceuticals |
| Konular: | |
| Online Erişim: | https://www.mdpi.com/1424-8247/17/12/1685 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|